Human Interleukin-2/IL-2 Recombinant Protein (RPES2167)
- SKU:
- RPES2167
- Product Type:
- Recombinant Protein
- Species:
- Human
- Research Area:
- Growth Factors & Cytokines
Frequently bought together:
Description
system_update_altDatasheet
Human Interleukin-2/IL-2 Recombinant Protein
Interleukin-2(IL-2) is an interleukin; a type of cytokine signaling molecule in the immune system;belongs to the IL-2 family. It is a powerful immunoregulatory lymphokine produced by T-cells in response to antigenic or mitogenic stimulation. IL-2/IL-2R signaling is required for T-cell proliferation and other fundamental functions that are essential for the immune response. IL-2 stimulates growth and differentiation of B-cells; NK cells; lymphokine-activated killer cells; monocytes; macrophages and oligodendrocytes.
Product Name: | Human Interleukin-2/IL-2 Recombinant Protein (RPES2167) |
Product Code: | RPES2167 |
Size: | 10µg |
Species: | Human |
Expressed Host: | Human Cells |
Synonyms: | Interleukin-2, IL-2, T-Cell Growth Factor, TCGF, Aldesleukin, IL4 |
Accession: | P60568 |
Sequence: | Ala21-Thr153 |
Fusion tag: | C-6His |
Activity: | Measured in a cell proliferation assay using CTLL?2 mouse cytotoxic T cells. The ED50 for this effect is ?1×107 IU/mg |
Endotoxin: | <1.0 EU per µg as determined by the LAL method. |
Protein Construction: | Recombinant Human Interleukin-2 is produced by our Mammalian expression system and the target gene encoding Ala21-Thr153 is expressed with a 6His tag at the C-terminus. |
Purity: | > 95 % as determined by reducing SDS-PAGE. |
Mol Mass: | 16.4 kDa |
AP Mol Mass: | 16 kDa |
Formulation: | Lyophilized from a 0.2 µm filtered solution of 20mM PB;150mM NaCl;pH 7.4. |
Shipping: | This product is provided as lyophilized powder which is shipped with ice packs. |
Stability and Storage: | Lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months. |